Reasons for participating in randomised controlled trials: conditional altruism and considerations for self

Sharon Katrina McCann, Marion Kay Campbell, Vikki Ann Entwistle

Research output: Contribution to journalArticle

138 Citations (Scopus)
3 Downloads (Pure)

Abstract

Background: Randomised controlled trials of healthcare interventions depend on the participation of volunteers who might not derive any personal health benefit from their participation. The idea that altruistic-type motives are important for trial participation is understandably widespread, but recent studies suggest considerations of personal benefit can influence participation decisions in various ways.

Methods: Non-participant observation of recruitment consultations (n = 25) and in-depth interviews with people invited to participate in the UK REFLUX trial (n = 13).

Results: Willingness to help others and to contribute towards furthering medical knowledge featured strongly among the reasons people gave for being interested in participating in the trial. But decisions to attend recruitment appointments and take part were not based solely on consideration of others. Rather, they were presented as conditional on individuals additionally perceiving some benefit (and no significant disadvantage) for themselves. Potential for personal benefit or disadvantage could be seen in both the interventions being evaluated and trial processes.

Conclusions: The term 'conditional altruism' concisely describes the willingness to help others that may initially incline people to participate in a trial, but that is unlikely to lead to trial participation in practice unless people also recognise that participation will benefit them personally. Recognition of conditional altruism has implications for planning trial recruitment communications to promote informed and voluntary trial participation.

Original languageEnglish
Pages (from-to)31
Number of pages10
JournalTrials
Volume11
DOIs
Publication statusPublished - 22 Mar 2010

Keywords

  • gastroesophageal-reflux disease
  • clinical-trials
  • informed-consent
  • Nissen fundoplication
  • random allocation
  • natural-history
  • ethical aspects
  • health-care
  • cancer
  • recruitment

Cite this

Reasons for participating in randomised controlled trials : conditional altruism and considerations for self. / McCann, Sharon Katrina; Campbell, Marion Kay; Entwistle, Vikki Ann.

In: Trials, Vol. 11, 22.03.2010, p. 31.

Research output: Contribution to journalArticle

@article{38283a122ef44c048fae544297dea0a1,
title = "Reasons for participating in randomised controlled trials: conditional altruism and considerations for self",
abstract = "Background: Randomised controlled trials of healthcare interventions depend on the participation of volunteers who might not derive any personal health benefit from their participation. The idea that altruistic-type motives are important for trial participation is understandably widespread, but recent studies suggest considerations of personal benefit can influence participation decisions in various ways.Methods: Non-participant observation of recruitment consultations (n = 25) and in-depth interviews with people invited to participate in the UK REFLUX trial (n = 13).Results: Willingness to help others and to contribute towards furthering medical knowledge featured strongly among the reasons people gave for being interested in participating in the trial. But decisions to attend recruitment appointments and take part were not based solely on consideration of others. Rather, they were presented as conditional on individuals additionally perceiving some benefit (and no significant disadvantage) for themselves. Potential for personal benefit or disadvantage could be seen in both the interventions being evaluated and trial processes.Conclusions: The term 'conditional altruism' concisely describes the willingness to help others that may initially incline people to participate in a trial, but that is unlikely to lead to trial participation in practice unless people also recognise that participation will benefit them personally. Recognition of conditional altruism has implications for planning trial recruitment communications to promote informed and voluntary trial participation.",
keywords = "gastroesophageal-reflux disease, clinical-trials, informed-consent, Nissen fundoplication, random allocation, natural-history, ethical aspects, health-care, cancer, recruitment",
author = "McCann, {Sharon Katrina} and Campbell, {Marion Kay} and Entwistle, {Vikki Ann}",
year = "2010",
month = "3",
day = "22",
doi = "10.1186/1745-6215-11-31",
language = "English",
volume = "11",
pages = "31",
journal = "Trials",
issn = "1745-6215",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Reasons for participating in randomised controlled trials

T2 - conditional altruism and considerations for self

AU - McCann, Sharon Katrina

AU - Campbell, Marion Kay

AU - Entwistle, Vikki Ann

PY - 2010/3/22

Y1 - 2010/3/22

N2 - Background: Randomised controlled trials of healthcare interventions depend on the participation of volunteers who might not derive any personal health benefit from their participation. The idea that altruistic-type motives are important for trial participation is understandably widespread, but recent studies suggest considerations of personal benefit can influence participation decisions in various ways.Methods: Non-participant observation of recruitment consultations (n = 25) and in-depth interviews with people invited to participate in the UK REFLUX trial (n = 13).Results: Willingness to help others and to contribute towards furthering medical knowledge featured strongly among the reasons people gave for being interested in participating in the trial. But decisions to attend recruitment appointments and take part were not based solely on consideration of others. Rather, they were presented as conditional on individuals additionally perceiving some benefit (and no significant disadvantage) for themselves. Potential for personal benefit or disadvantage could be seen in both the interventions being evaluated and trial processes.Conclusions: The term 'conditional altruism' concisely describes the willingness to help others that may initially incline people to participate in a trial, but that is unlikely to lead to trial participation in practice unless people also recognise that participation will benefit them personally. Recognition of conditional altruism has implications for planning trial recruitment communications to promote informed and voluntary trial participation.

AB - Background: Randomised controlled trials of healthcare interventions depend on the participation of volunteers who might not derive any personal health benefit from their participation. The idea that altruistic-type motives are important for trial participation is understandably widespread, but recent studies suggest considerations of personal benefit can influence participation decisions in various ways.Methods: Non-participant observation of recruitment consultations (n = 25) and in-depth interviews with people invited to participate in the UK REFLUX trial (n = 13).Results: Willingness to help others and to contribute towards furthering medical knowledge featured strongly among the reasons people gave for being interested in participating in the trial. But decisions to attend recruitment appointments and take part were not based solely on consideration of others. Rather, they were presented as conditional on individuals additionally perceiving some benefit (and no significant disadvantage) for themselves. Potential for personal benefit or disadvantage could be seen in both the interventions being evaluated and trial processes.Conclusions: The term 'conditional altruism' concisely describes the willingness to help others that may initially incline people to participate in a trial, but that is unlikely to lead to trial participation in practice unless people also recognise that participation will benefit them personally. Recognition of conditional altruism has implications for planning trial recruitment communications to promote informed and voluntary trial participation.

KW - gastroesophageal-reflux disease

KW - clinical-trials

KW - informed-consent

KW - Nissen fundoplication

KW - random allocation

KW - natural-history

KW - ethical aspects

KW - health-care

KW - cancer

KW - recruitment

U2 - 10.1186/1745-6215-11-31

DO - 10.1186/1745-6215-11-31

M3 - Article

VL - 11

SP - 31

JO - Trials

JF - Trials

SN - 1745-6215

ER -